The overall analysis revealed that the CASC15 and PPP1R26-AS1 lncRNAs are significantly upregulated in all tumor cells (primary stage 4 tumor, DTCs, and relapsed DTCs) and also in the publicly available database, which makes them strong candidates for marker lncRNA genes for the identification of neuroblastoma progression. This evidence concerns the gene PPP1R26 and neoplasm.